(OST)

Kathryn S Beauchemin1, Judit Kun1, Bradley Groveman2

  • 1Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.

PLoS pathogens
|January 12, 2026
PubMed
概括

研究人员确定了寡糖转移酶 (OST) 复合体作为一种新治疗病的新治疗标. 抑制OST有效地治疗细胞和器官模型中的子感染,为治疗这些致命的神经退行性疾病提供了潜在的新途径.